In an innovative biomedicine laboratory at Polytechnique Montréal, researchers are laying the groundwork for Canada’s future pandemic preparedness. Employing advanced techniques in protein purification and vaccine development, the lab is part of the federal Ramp Up initiative, a collaborative effort aimed at strengthening the nation’s biomanufacturing capabilities. As the world continues to grapple with the ramifications of COVID-19, the Polytechnique team is determined to enhance Canada’s readiness for inevitable public health crises.
A New Era of Collaboration
The Ramp Up initiative, launched in 2024, represents a significant shift in how Canada approaches biomanufacturing. Spearheaded by Gregory De Crescenzo, a full professor in the Department of Chemical Engineering, the programme integrates efforts from multiple research institutions, including Université Laval and Simon Fraser University. Rather than operating in isolation, these institutions are uniting to address critical gaps in the biomanufacturing sector, which were starkly highlighted during the pandemic.
De Crescenzo emphasises the need for a comprehensive approach: “It’s not a matter of if, but when,” he states, underscoring the urgency of preparedness in a world where the threat of infectious diseases looms large. The lab itself, with its bustling atmosphere of researchers clad in white lab coats, provides a glimpse into the intricate work being conducted. From growing animal proteins in vibrant solutions to analysing antibodies produced by cells, every aspect of the research is meticulously designed to enhance vaccine development processes.
Bridging the Gaps in Biomanufacturing
One of the primary objectives of the Ramp Up initiative is to rectify the deficiencies exposed by the COVID-19 pandemic. De Crescenzo notes that Canada’s biomedical production capacity was inadequate, leading to heavy reliance on imports and a fragmented response from government, academia, and industry stakeholders. The initiative aims to create a cohesive framework that fosters collaboration across these sectors, ensuring a more robust response to future health emergencies.
Students and researchers at Polytechnique Montréal are equipped with the same cutting-edge tools found in commercial laboratories, allowing them to work with a high degree of professionalism. They engage in the production of vital components, such as antibodies and viral proteins, which are essential for developing vaccines and therapeutics. “Everything is normalised, is written, carefully verified, approved, transferred to the industries,” explains De Crescenzo, likening their work to crafting recipes for successful biomedical solutions.
Building Public Trust and Engagement
The success of the Ramp Up initiative hinges not only on scientific advancements but also on rebuilding public trust in vaccines and biomedical practices. De Crescenzo believes that transparency is key to alleviating vaccine hesitancy, a sentiment echoed by Master’s student Marie-Gael Tchummo. Having experienced scepticism from friends and family regarding the rapid development of COVID-19 vaccines, Tchummo has taken it upon herself to educate those around her about the science behind vaccine production. “With the public, we need to be transparent,” she asserts, emphasising the importance of open communication in fostering trust.
The initiative also acknowledges the need for multi-sectoral collaboration in pandemic preparedness. Isaac Bogoch, an infectious disease specialist at the University of Toronto, highlights the importance of a holistic approach: “It’s a whole of government and a whole of society response. There’s not one lab that’s going to do it.” The ongoing work of the Ramp Up initiative exemplifies this philosophy, as it seeks to integrate insights from various fields, including transportation and public health infrastructure, to create a more resilient system.
Investing in the Future
Health Canada has committed significant resources to bolster the nation’s pandemic response capabilities, investing over $2.5 billion in vaccine and biomanufacturing projects since 2020. This includes the establishment of biocontainment facilities and research hubs across the country, which are vital for ensuring timely access to life-saving medicines during health emergencies.
As part of a broader strategy, the government is preparing to unveil a new emergency response plan by 2027, aimed at improving coordination among different levels of government, international partners, and Indigenous communities. With over 15,000 skilled workers projected to be needed in the biomanufacturing sector by 2029, Ramp Up’s efforts are a crucial step toward building a workforce capable of navigating the challenges of future pandemics.
Why it Matters
The work being conducted at Polytechnique Montréal is not merely a response to the pandemic; it represents a transformative shift in how Canada approaches health crises. By fostering collaboration across sectors, investing in biomanufacturing, and prioritising public trust, the Ramp Up initiative is setting a precedent for a more resilient and prepared nation. The lessons learned from COVID-19 are being actively applied, ensuring that Canada is not only ready for the next health emergency but is also leading by example on the global stage.
